Resultados da pesquisa - brain ((((((tumor 18) OR (tumor a))) or (tumor _))) or (tumor rna)) treat

Pesquisas alternativas:
tumor rna » tumor renal (Expandir a Pesquisa)
tumor 18 » tumor 1 (Expandir a Pesquisa)

1

TMIC-12. TUMOR-HOMING RNA-NANOPARTICLES REPROGRAM IMMUNE CELLS IN THE BRAIN TUMOR MICROENVIRONMENT

TMIC-12. TUMOR-HOMING RNA-NANOPARTICLES REPROGRAM IMMUNE CELLS IN THE BRAIN TUMOR MICROENVIRONMENT

Por Grippin, Adam, Mendez-Gomez, Hector, Wummer, Brandon, Wildes, Tyler, Dyson, Kyle, Valladares, Daniel, Dobson, Jon, Sayour, Elias, Mitchell, Duane
Publicado no Neuro Oncol (2018)

“...BACKGROUND: Brain tumors are particularly difficult to treat due to their relative isolation behind...”
Obter o texto integral
Obter o texto integral

Artigo

2

Focused Ultrasound-enabled Brain Tumor Liquid Biopsy

Focused Ultrasound-enabled Brain Tumor Liquid Biopsy

Por Zhu, Lifei, Cheng, Galen, Ye, Dezhuang, Nazeri, Arash, Yue, Yimei, Liu, Weijun, Wang, Xiaowei, Dunn, Gavin P., Petti, Allegra A., Leuthardt, Eric C., Chen, Hong
Publicado no Sci Rep (2018)

“... biomarkers in various cancers, limited progress has been made for brain tumors. One major obstacle...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor model.

Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor model.

Por Maite Verreault, Sherry A Weppler, Amelia Stegeman, Corinna Warburton, Dita Strutt, Dana Masin, Marcel B Bally
Publicado em 2013-01-01

“... validation studies were carried out using siRNA-based gene silencing methods in a panel of three commercially...”
Obter o texto integral

Artigo

4

Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model

Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model

Por Verreault, Maite, Weppler, Sherry A., Stegeman, Amelia, Warburton, Corinna, Strutt, Dita, Masin, Dana, Bally, Marcel B.
Publicado em 2013

“... validation studies were carried out using siRNA-based gene silencing methods in a panel of three commercially...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

5

P04.36 Technology for the research of Primary and Partially Passaged Cell Cultures by Human Glioblastoma is necessary for studying the characteristics of a tumor and searching for therapy

P04.36 Technology for the research of Primary and Partially Passaged Cell Cultures by Human Glioblastoma is necessary for studying the characteristics of a tumor and searching for therapy

Por Pavlova, G, Yakovleva, K, Pustogarov, N, Savchenko, E, Goryaynov, S, Revishchin, A, Kopylov, A
Publicado no Neuro Oncol (2018)

“...BACKGROUND: Glioblastoma is a heterogeneous brain tumor that can be characterized as a socially...”
Obter o texto integral
Obter o texto integral

Artigo

6

Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin.

Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin.

Por Janss, A. J., Maity, A., Tang, C. B., Muschel, R. J., McKenna, W. G., Sutton, L., Phillips, P. C.
Publicado em 2001

“... is a common response of brain tumor cells to chemotherapy with topoisomerase I inhibitors and that a...”
Obter o texto integral
Obter o texto integral

Artigo

7

Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors

Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors

Por Choi, Seung Ah, Choi, Jung Won, Wang, Kyu-Chang, Phi, Ji Hoon, Lee, Ji Yeoun, Park, Kyung Duk, Eum, Dayoung, Park, Sung-Hye, Kim, Il Han, Kim, Seung-Ki
Publicado no Neuro Oncol (2015)

“... tumors. Cells from brain tumors with high aldehyde dehydrogenase (ALDH) activity have a number...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats

Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats

Por Liu, Shie-Chau, Alomran, Reem, Chernikova, Sophia B., Lartey, Fred, Stafford, Jason, Jang, Taichang, Merchant, Milton, Zboralski, Dirk, Zöllner, Stefan, Kruschinski, Anna, Klussmann, Sven, Recht, Lawrence, Brown, J. Martin
Publicado em 2014

“... clinically relevant model using autochthonous brain tumors in immune competent hosts. METHODS: We used NOX-A...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

9

Progesterone receptor membrane component 1 inhibits tumor necrosis factor alpha induction of gene expression in neural cells

Progesterone receptor membrane component 1 inhibits tumor necrosis factor alpha induction of gene expression in neural cells

Por Intlekofer, Karlie A., Clements, Kelsey, Woods, Haley, Adams, Hillary, Suvorov, Alexander, Petersen, Sandra L.
Publicado no PLoS One (2019)

“... functions in cells of these regions, we compared transcriptomes of control siRNA-treated and Pgrmc1 siRNA...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

10

Gene- and viral-based therapies for brain tumors

Gene- and viral-based therapies for brain tumors

Por Asadi-Moghaddam, Kaveh, Chiocca, E. Antonio
Publicado em 2009

“... genetic material to fight or prevent disease with brain tumors being among one of the first human...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

11

ATF4 contributes to autophagy and survival in sunitinib treated brain tumor initiating cells (BTICs)

ATF4 contributes to autophagy and survival in sunitinib treated brain tumor initiating cells (BTICs)

Por Moeckel, Sylvia, LaFrance, Kelly, Wetsch, Julia, Seliger, Corinna, Riemenschneider, Markus J., Proescholdt, Martin, Hau, Peter, Vollmann-Zwerenz, Arabel
Publicado no Oncotarget (2019)

“...Receptor tyrosine kinase (RTK) pathways are known to play an important role in tumor cell...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

12

A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model

A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model

Por Yang, Shicheng, Archer, Gary E., Flores, Catherine E., Mitchell, Duane A., Sampson, John H.
Publicado em 2013

“... and imposes a novel T cell-based therapeutic with the potential to treat brain tumors and other cancers....”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

13

Pediatric Phase II Trials of Poly-ICLC in the Management of Newly Diagnosed and Recurrent Brain Tumors

Pediatric Phase II Trials of Poly-ICLC in the Management of Newly Diagnosed and Recurrent Brain Tumors

Por Hartman, Lisa L.R., Crawford, John R., Makale, Milan T., Milburn, Mehrzad, Joshi, Shweta, Salazar, Andres M., Hasenauer, Beth, VandenBerg, Scott R., MacDonald, Tobey J., Durden, Donald L.
Publicado no J Pediatr Hematol Oncol (2014)

“... tumors. Poly-ICLC is a synthetic double-stranded RNA that has direct antiviral, antineoplastic...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

14

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

Por Armand, Jean-Pierre, Ribrag, Vincent, Harrousseau, Jean-Luc, Abrey, Lauren
Publicado em 2007

“... of Hodgkin’s lymphoma and brain tumors and, to a lesser extent, Non-Hodgkin’s lymphoma and primary central...”
Obter o texto integral
Obter o texto integral

Artigo

15

Dexamethasone Alleviates Tumor-Associated Brain Damage and Angiogenesis

Dexamethasone Alleviates Tumor-Associated Brain Damage and Angiogenesis

Por Fan, Zheng, Sehm, Tina, Rauh, Manfred, Buchfelder, Michael, Eyupoglu, Ilker Y., Savaskan, Nicolai E.
Publicado em 2014

“... treated with dexamethasone (DEXA), a steroidal anti-inflammatory drug with pleiotropic action profile...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression

Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression

Por Yang, Eric V., Kim, Seung-jae, Donovan, Elise L., Chen, Min, Gross, Amy C., Webster Marketon, Jeanette I., Barsky, Sanford H., Glaser, Ronald
Publicado em 2008

“...Studies suggest that stress can be a co-factor for the initiation and progression of cancer...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

17

microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis

microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis

Por Bhere, Deepak, Tamura, Kaoru, Wakimoto, Hiroaki, Choi, Sung Hugh, Purow, Benjamin, Debatisse, Jeremy, Shah, Khalid
Publicado no Neuro Oncol (2018)

“.... In vivo, a single administration of AAV–miR-7 significantly decreases tumor volumes, upregulates DR5...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

18

Asparagine Depletion Potentiates the Cytotoxic Effect of Chemotherapy Against Brain Tumors

Asparagine Depletion Potentiates the Cytotoxic Effect of Chemotherapy Against Brain Tumors

Por Panosyan, Eduard H., Wang, Yuntao, Xia, Peng, Lee, Wai-Nang Paul, Pak, Youngju, Laks, Dan R., Lin, Henry J., Moore, Theodore B., Cloughesy, Timothy F., Kornblum, Harley I., Lasky, Joseph L.
Publicado em 2014

“...Targeting amino acid metabolism has therapeutic implications for aggressive brain tumors...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

19

Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines

Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines

Por Zomerman, Walderik W., Plasschaert, Sabine L. A., Diks, Sander H., Lourens, Harm-Jan, Meeuwsen-de Boer, Tiny, Hoving, Eelco W., den Dunnen, Wilfred F. A., de Bont, Eveline S. J. M.
Publicado no PLoS One (2015)

“...Recent clinical trials investigating receptor tyrosine kinase (RTK) inhibitors showed a limited...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

20

Induction and down-regulation of PLK, a human
serine/threonine kinase expressed in proliferating cells and
tumors.

Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors.

Por Holtrich, U, Wolf, G, Bräuninger, A, Karn, T, Böhme, B, Rübsamen-Waigmann, H, Strebhardt, K
Publicado em 1994

“... cytokines in macrophages, totally abrogated the expression of PLK mRNA. In line with a function of PLK mRNA...”
Obter o texto integral
Obter o texto integral

Artigo

1
2
3
4
5
6
7
8
9
10
11
Seguinte
[22]